Founding Managing Director for Valence Advantage Life Sciences
Dr. Leheny is a Founding Managing Director for Valence Advantage Life Sciences, a life science venture firm based in New York. She has extensive experience in the life science field, as a scientist, as a research analyst at several investment banks, and as a venture capital investor. Dr. Leheny has over 25 years experience in the life sciences industry. Prior to Valence, she co-founded Caxton Advantage Venture Partners, from which Valence Life Sciences emerged. Before that, she was a Senior Vice President and Head of the biotechnology research team at Lehman Brothers. She also led the biotechnology research team at UBS Warburg, and started her biotechnology research career at Hambrecht and Quist. Dr. Leheny obtained an A.B in Chemistry with honors from Harvard College, and a Ph.D. in chemistry from Columbia University. She did post-doctoral work at the University of California, Berkeley, where she was an NIH fellow and a lecturer.